These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The world of serotonin and its receptors. Physiopathologic, clinical, and therapeutic aspects]. Marco Igual M Med Clin (Barc); 1993 Jun; 101(4):144-53. PubMed ID: 8355545 [No Abstract] [Full Text] [Related]
5. 5HT3-antagonist receptors: their role in drug-induced emesis. Dieras V; Extra JM; Le Bonniec M; Madelaine I; Espie M; Marty M Nouv Rev Fr Hematol (1978); 1990; 32(6):449-52. PubMed ID: 1983228 [TBL] [Abstract][Full Text] [Related]
6. Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors. Aellig WH Adv Neurol; 1982; 33():321-4. PubMed ID: 7055012 [No Abstract] [Full Text] [Related]
11. Basic mechanisms of antimigraine drugs. Fozard JR Adv Neurol; 1982; 33():295-307. PubMed ID: 7034488 [No Abstract] [Full Text] [Related]
12. Are vascular mechanisms involved in antidepressant action? DeFeudis FV Gen Pharmacol; 1985; 16(6):553-6. PubMed ID: 3910516 [TBL] [Abstract][Full Text] [Related]
13. The importance of 5-hydroxytryptamine receptors in the gut. Read NW; Gwee KA Pharmacol Ther; 1994; 62(1-2):159-73. PubMed ID: 7991641 [TBL] [Abstract][Full Text] [Related]
15. [New therapeutic possibilities with drugs affecting serotonin receptors]. Spigset O Tidsskr Nor Laegeforen; 1992 May; 112(13):1700-4. PubMed ID: 1509427 [TBL] [Abstract][Full Text] [Related]
16. Involvement of 5-HT1A and 5-HT2 receptor in cisplatin induced emesis in dogs. Gupta YK; Sharma SS Indian J Physiol Pharmacol; 2002 Oct; 46(4):463-7. PubMed ID: 12683222 [TBL] [Abstract][Full Text] [Related]
17. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs]. Amelin AV; Skoromets AA; Ignatov IuD Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805 [No Abstract] [Full Text] [Related]
18. Importance of headache. Peatfield RC Curr Med Res Opin; 2001; 17 Suppl 1():s1-3. PubMed ID: 12463269 [No Abstract] [Full Text] [Related]
19. [Type-3 serotonin receptor blockaders (5-HT3)--a new class of antiemetic preparations]. Legeza VI Eksp Klin Farmakol; 1994; 57(4):72-5. PubMed ID: 7950795 [No Abstract] [Full Text] [Related]
20. Effects on arterial receptors of ergot derivatives used in migraine. Müller-Schweinitzer E; Fanchamps A Adv Neurol; 1982; 33():343-56. PubMed ID: 6275676 [No Abstract] [Full Text] [Related] [Next] [New Search]